MLchartDataset catalogue

IMMU-106

Term · Oncology and biomedicine · MLC-T-ONC-004194

A substance being studied in the treatment of several types of lymphoma. It binds to the protein CD20, which is found on B cells (a type of immune system cell) and some types of lymphoma cells. This causes the immune system to kill the cancer cells. IMMU-106 is a type of monoclonal antibody. Also called hA20, HCD20, and veltuzumab.

Table 1. Record
IdentifierMLC-T-ONC-004194
FieldOncology and biomedicine
ExpansionshA20; veltuzumab
SynonymsHCD20
ReferencesNCI Dictionary of Cancer Terms
Record as JSON 
{
  "id": "MLC-T-ONC-004194",
  "term": "IMMU-106",
  "field": "Oncology and biomedicine",
  "definition": "A substance being studied in the treatment of several types of lymphoma. It binds to the protein CD20, which is found on B cells (a type of immune system cell) and some types of lymphoma cells. This causes the immune system to kill the cancer cells. IMMU-106 is a type of monoclonal antibody. Also called hA20, HCD20, and veltuzumab.",
  "expansions": [
    "hA20",
    "veltuzumab"
  ],
  "synonyms": [
    "HCD20"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/immu-106/"
}

Record 9,066 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.